Mesa Laboratories, Inc. (NASDAQ:MLAB) Holdings Raised by ExodusPoint Capital Management LP

ExodusPoint Capital Management LP lifted its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB - Free Report) by 283.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,692 shares of the medical instruments supplier's stock after buying an additional 7,167 shares during the period. ExodusPoint Capital Management LP owned approximately 0.18% of Mesa Laboratories worth $1,278,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. FMR LLC lifted its position in Mesa Laboratories by 34.1% during the 3rd quarter. FMR LLC now owns 393 shares of the medical instruments supplier's stock worth $51,000 after acquiring an additional 100 shares in the last quarter. Amundi raised its stake in shares of Mesa Laboratories by 81.6% during the fourth quarter. Amundi now owns 661 shares of the medical instruments supplier's stock valued at $91,000 after purchasing an additional 297 shares during the period. KLP Kapitalforvaltning AS acquired a new position in shares of Mesa Laboratories during the fourth quarter worth $132,000. Captrust Financial Advisors purchased a new position in shares of Mesa Laboratories in the third quarter valued at $207,000. Finally, Berry Wealth Group LP increased its stake in Mesa Laboratories by 5.3% during the 4th quarter. Berry Wealth Group LP now owns 1,657 shares of the medical instruments supplier's stock worth $219,000 after buying an additional 83 shares during the period. Hedge funds and other institutional investors own 90.60% of the company's stock.

Insider Buying and Selling

In other Mesa Laboratories news, CEO Gary M. Owens sold 21,000 shares of the firm's stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $123.91, for a total transaction of $2,602,110.00. Following the completion of the transaction, the chief executive officer now directly owns 43,337 shares of the company's stock, valued at $5,369,887.67. This trade represents a 32.64 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 4.40% of the company's stock.

Remove Ads

Mesa Laboratories Stock Down 0.4 %

MLAB stock traded down $0.49 during trading on Tuesday, reaching $113.60. The stock had a trading volume of 17,397 shares, compared to its average volume of 38,730. The firm has a fifty day moving average price of $129.73 and a 200 day moving average price of $128.11. The company has a current ratio of 0.71, a quick ratio of 0.53 and a debt-to-equity ratio of 0.61. The company has a market capitalization of $617.28 million, a P/E ratio of -2.46 and a beta of 0.92. Mesa Laboratories, Inc. has a 1-year low of $83.68 and a 1-year high of $155.12.

Mesa Laboratories (NASDAQ:MLAB - Get Free Report) last issued its quarterly earnings results on Tuesday, February 4th. The medical instruments supplier reported $2.07 EPS for the quarter, beating analysts' consensus estimates of $1.41 by $0.66. Mesa Laboratories had a positive return on equity of 30.23% and a negative net margin of 104.92%. On average, equities analysts anticipate that Mesa Laboratories, Inc. will post 8 earnings per share for the current year.

Mesa Laboratories Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, June 16th. Stockholders of record on Friday, May 30th will be given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.56%. The ex-dividend date is Friday, May 30th. Mesa Laboratories's payout ratio is currently -1.38%.

About Mesa Laboratories

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.